|
Sign In to gain access to subscriptions and/or personal tools.
|
Shedding Light on Vitamin D and Integrative Oncology
Ira Cantor*
* To whom correspondence should be addressed. E-mail: isc{at}steinermed.com.
 |
Abstract |
|---|
Studies show an important relationship between vitamin D and malignancies, both in prevention and treatment. The extraskeletal actions of vitamin D relevant to oncology include being proapoptotic, antimetastatic, antiangiogenic, antiinflammatory, prodifferentiating, and immunomodulating. Widespread and severe vitamin D deficiencies exist worldwide. Decreased sun exposure, caused by lifestyle changes, as well as fear of skin cancers, is the main cause of these deficiencies. Recommended daily oral intakes, as well as suggested blood levels, are below optimal levels suggested by studies. Improvement in vitamin D status, through lifestyle changes and supplementation, can be of profound benefit regarding the occurrence and mortality of malignancies.
First published on May 27, 2008, doi:10.1177/1534735408319062
Integrative Cancer Therapies 2008;7:81.
A more recent version of this article appeared on June 1, 2008

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. A. Newton-Bishop, S. Beswick, J. Randerson-Moor, Y.-M. Chang, P. Affleck, F. Elliott, M. Chan, S. Leake, B. Karpavicius, S. Haynes, et al.
Serum 25-Hydroxyvitamin D3 Levels Are Associated With Breslow Thickness at Presentation and Survival From Melanoma
J. Clin. Oncol.,
November 10, 2009;
27(32):
5439 - 5444.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|